CDC Website CDC Website

To Join the NPIN community or

Home » Persons With TB » Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)

Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed)

The purpose of this Funding Opportunity is to stimulate new and innovative multidisciplinary research in the area of long acting therapeutics for HIV and HIV-associated tuberculosis (TB) and viral hepatitis B and C. Applications are sought that lead to new effective therapies for administration once per month or less frequently as oral, injectable, implantable, or transdermal products.

Application Due Date
7/28/20
Project Start Date
3/1/21
Application Contact
Jenna
Briggs
Grants Management Specialist
301-761-5137
jenna.briggs@nih.gov
Technical Contact
Marina
N
Protopopova, PhD
Program Officer
marina.protopopova@nih.gov
301-761-7653
Fund Duration
Five years.
Subjects
Audiences

Fund Number: 

345532

Fund ID: 

RFA-AI-20-024

Last modified: 

3/25/20